You Position: Home > Paper
卵巢癌化学药物治疗耐药的研究现状和发展趋势
( views:299, downloads:36 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Issue:
- 12
- DOI:
- 10.3760/j.issn:0529-567X.2003.12.018
- Key Word:
- No keyword available
Abstract： @@ 卵巢癌死亡率居妇科恶性肿瘤之首,确诊时临床期别较晚及化学药物治疗(化疗)耐药是造成患者总体预后不良的主要原因[1].化疗是卵巢癌术后的主要辅助治疗手段,如何克服或预防耐药成为临床研究的热点和难点问题.本文综述了近年来化疗耐药的研究现状及发展趋势.现报道如下.
- [1]程国钧,李亚里,祝华,等.不同方式诱导人卵巢癌顺铂耐药细胞株的比较[J].2001,(4).
- [2]Shane K, Green,Mikael C I, Karlsson,Jeffrey V, Ravetch,etc.Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer.[J].2002,62.
- [3]Wu GenSheng,Ding Zhenhua.Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.[J].2002,21(1).
- [4]Fruehauf JP.In vitro assay-assisted treatment selection for women with breast or ovarian cancer.[J].2002,9(3).
- [5]Sood AK,Buller RE.Drug resistance in ovarian cancer: from the laboratory to the clinic.[J].1998,92(2).
- [6]Sylvie, Maubant,Séverine, Cruet-Hennequart,Laurent, Poulain,etc.Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.[J].2002,97.
- [7]Kerbel RS,Frankel A,Green SK.Adhesion-dependent multicellular drug resistance.[J].1999,14(2).
- [8]Armstrong DK.Relapsed ovarian cancer: challenges and management strategies for a chronic disease.[J].2002,7(Suppl.5).
- [9]H. Lincet,L. Poulain,J.S. Remy,etc.The p21cip1/waf1 cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells[J].2000,161(1).
- [10]Kassim, S. K.,Ali, H. S.,Sallam, M. M.,etc.Increased bcl-2 Expression is Associated with Primary Resistance to Chemotherapy in Human Epithelial Ovarian Cancer[J].1999,32(5).
- [11]Robert W, Holloway,Rita S, Mehta,Neil J, Finkler,etc.Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.[J].2002,87(1).
- [12]Tajiri H,Hama S,Hiura M,etc.Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and Vinca alkaloids of human ovarian cancer cells.[J].2001,21(4A).
- [13]Brady MF,Rose PG,Letvak L,etc.Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study.[J].2001,19(12).
- [14]Eloisi C. Lopes,Glenda Ernst,Paula Aulicino,etc.Dissimilar invasive and metastatic behavior of vincristine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia[J].2002,19(4).